US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Sep 24, 2025 (11 months ago)

Entecavir Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

What was recalled

Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

Recalling firm
Zydus Pharmaceuticals (USA) Inc
NDC code
68382-921-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0002-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Entecavir recalls

See all
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc NDC 68382-920-06 D-0001-2026
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed Impurity/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc NDC 68382-921-06 D-0657-2025
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed Impurity/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc NDC 68382-920-06 D-0656-2025
Class II · Moderate risk Terminated

Entecavir Tablets 0.5 mg

Reason Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.

Hetero USA Inc NDC 31722-833-30 D-1095-2017
Class II · Moderate risk Terminated

Entecavir

Reason Labeling: Label Mixup: ENTECAVIR, Tablet, 0.5 mg may be potentially mis-labeled as one of the following drugs: ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD30140_25, EXP: 5/7/2014; aMILoride HCl, Tablet, 5 mg, NDC 64980015101, Pedigree: W003686, EXP: 6/26/2014; ATOMOXETINE HCL, Capsule, 80 mg, NDC 00002325030, Pedigree: AD60272_49, EXP: 5/22/2014.

Aidapak Services, LLC D-770-2014